Transplant breakdown? new study checks organ fluid for hidden germs
NCT ID NCT07651137
First seen Jun 27, 2026 ยท Last updated Jun 27, 2026
Summary
This study looks at whether testing the liquid used to preserve donor livers and kidneys can predict infections in recipients. Researchers will check if bacteria or fungi in that fluid match infections that develop after transplant. The goal is to see if this simple test could help doctors treat infections earlier and improve patient outcomes. The study involves 1,400 adults getting liver or kidney transplants at one Italian hospital.
What this could mean
Our plain-language read of the trial. This is informational only โ not medical advice or a prediction.
- Active substance
- microbiological culture of perfusion fluid
- What this could lead to
- If successful, this could lead to better infection management and fewer complications for transplant patients by identifying hidden risks early.
- What could go wrong
- This is an observational study, not a treatment trial. It may not prove that testing improves outcomes, and results might not apply to all transplant centers.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for BACTERIAL INFECTION are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
IRCCS Azienda Ospedaliero-Universitaria di Bologna
Bologna, Italy, 40128, Italy
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can personalized antibiotics outsmart resistant bacteria in liver transplants?
- Could the choice of anesthesia quiet the Body's surgical stress response?
- A simple blood test could spot kidney transplant rejection early
- Can your gut bacteria change how transplant drugs work?
- Blood test may take the guesswork out of transplant drug dosing
- Immunotherapy may treat skin cancer in kidney transplant patients without rejection